92 related articles for article (PubMed ID: 8009887)
1. Importance of metabolic stability and hepatic distribution to the pharmacokinetic profile of amlodipine.
Walker DK; Humphrey MJ; Smith DA
Xenobiotica; 1994 Mar; 24(3):243-50. PubMed ID: 8009887
[TBL] [Abstract][Full Text] [Related]
2. Disposition of amphotericin B in the isolated perfused rat liver.
Hong Y; Ramzan I; McLachlan AJ
J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
Abernethy DR
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
[TBL] [Abstract][Full Text] [Related]
4. Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonists.
Betts A; Atkinson F; Gardner I; Fox D; Webster R; Beaumont K; Morgan P
Drug Metab Dispos; 2007 Aug; 35(8):1435-45. PubMed ID: 17502340
[TBL] [Abstract][Full Text] [Related]
5. Drug metabolism and pharmacokinetics of 4-substituted methoxybenzoyl-aryl-thiazoles.
Li CM; Lu Y; Narayanan R; Miller DD; Dalton JT
Drug Metab Dispos; 2010 Nov; 38(11):2032-9. PubMed ID: 20675405
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry.
Suchanova B; Kostiainen R; Ketola RA
Eur J Pharm Sci; 2008 Jan; 33(1):91-9. PubMed ID: 18055188
[TBL] [Abstract][Full Text] [Related]
7. Sulfobromophthalein metabolism in isolated perfused rat liver. Factors determining the applicability of the model.
Céspedes JM; Rodríguez Garay EA
Acta Physiol Lat Am; 1979; 29(4-5):207-15. PubMed ID: 263170
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
Egfjord M
Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate.
Worboys PD; Bradbury A; Houston JB
Drug Metab Dispos; 1997 Apr; 25(4):460-7. PubMed ID: 9107546
[TBL] [Abstract][Full Text] [Related]
10. Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
J Pharmacol Exp Ther; 1989 Sep; 250(3):1043-7. PubMed ID: 2778708
[TBL] [Abstract][Full Text] [Related]
11. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
[TBL] [Abstract][Full Text] [Related]
13. Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA.
Minchin RF; Carpenter D; Orr RJ
J Pharmacol Exp Ther; 2001 Mar; 296(3):1006-12. PubMed ID: 11181935
[TBL] [Abstract][Full Text] [Related]
14. Criticism of pharmacokinetic clearance concepts.
Keller F; Schoole J
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
[TBL] [Abstract][Full Text] [Related]
15. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
Sabouraud A; Redureau M; Gires P; Martinet M; Scherrmann JM
Drug Metab Dispos; 1993; 21(6):997-1002. PubMed ID: 7905405
[TBL] [Abstract][Full Text] [Related]
16. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
17. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
[TBL] [Abstract][Full Text] [Related]
19. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
Siebert GA; Hung DY; Chang P; Roberts MS
J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
[TBL] [Abstract][Full Text] [Related]
20. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency.
Gaillot J; Le Roux Y; Houghton GW; Dreyfus JF
Sleep; 1987; 10 Suppl 1():7-21. PubMed ID: 3438645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
